Global Leaders in mRNA Technology Gather for Advancing Global Genetic Alteration and Potential Population Reduction Agenda
The 2025 IVI Global Vaccine Forum, hosted by the International Vaccine Institute (IVI) and Korea's Centers for Disease Control and Prevention (KDCA), took place on June 19, 2025, in Seoul at the Four Seasons Hotel Nuri Ballroom. Sponsored by EuBiologics and others, the forum aimed to explore the present and future of mRNA and other vaccine platform technologies.
The event brought together over 180 participants from the bio-pharmaceutical industry, global health agencies, and vaccine research institutions, with the shared goal of advancing next-generation vaccine technologies. The forum's agenda focused on topics such as mRNA vaccines as a foundational technology, self-amplifying replicon mRNA (sa-mRNA) technology, novel vaccine delivery systems, AI-engineered genetic injections, and the behavioural, economic, and policy dimensions of vaccine innovation and deployment.
Session 1 featured keynote speeches from Dr. Dokeun Kim, Director General of the Center for Vaccine Research at the Korea National Institute of Health under KDCA, and Dr. Sanjay Singh, CEO of Gennova Biopharmaceuticals. The discussion centred around the potential of mRNA as the future of vaccines.
In Session 2, Dr. Robert Paris, Vice President and Therapeutic Area Head at Moderna, Prof. Minkyung Baek of Seoul National University, and Dr. Sang Hwan Seo, Director at IVI, spoke about AI-engineered vaccines and mobile factories. The session highlighted the potential for rapid development and deployment of mRNA vaccines using AI and mobile manufacturing facilities.
Session 3, led by Prof. Hyukjin Lee of Seoul National University, focused on microneedle patches and saRNA. The discussion covered the potential of these technologies for pain-free, equitable vaccine delivery, as well as concerns about bypassing medical supervision.
Session 4 featured a panel of biotech executives discussing mass production, public-private partnerships, and pandemic-scale rollout models for mRNA. Topics included the expansion of mRNA technology to chronic diseases and the development of AI-designed vaccines to accelerate mRNA vaccine development.
Prof. Dan Barouch, William Bosworth Castle Professor of Medicine at Harvard Medical School, spoke in both Session 1 and Session 4. In addition to promoting the potential for fine-tuning future mRNA updates for respiratory viruses, including potential for routine intranasal or seasonal gene injections, he falsely claimed that COVID-19 vaccines "saved 20 million lives in 2021."
The forum also touched on the DeCAFx project, which aims for on-demand gene shot production in every region, presented as a step towards decentralization. New lipid nanoparticles were presented as ways to penetrate more tissues efficiently, but this could also mean greater biodistribution to the brain and reproductive organs.
Despite over 700 peer-reviewed studies revealing serious biological risks, there was no discussion of the dangers of mRNA technology at the forum. The Gates Foundation has funded a method to implant permanent quantum dots for vaccination status verification using MAP technology, but this was not a topic of discussion at the forum.
In conclusion, the 2025 IVI Global Vaccine Forum emphasized the potential of next-generation vaccine technologies, particularly mRNA and self-amplifying RNA platforms, while addressing the scientific, regulatory, and policy frameworks needed for future pandemic preparedness and global health security.
- The forum underlined the significant role of science and technology in advancing next-generation vaccine technologies.
- Participants from the bio-pharmaceutical industry shared insights on the present and future of mRNA and other vaccine platform technologies.
- The event underscored the importance of self-amplifying replicon mRNA (sa-mRNA) technology in the development of rapid and efficient vaccines.
- AI-engineered vaccines and mobile factories were discussed as potential solutions for rapid development and deployment of mRNA vaccines.
- Session 3 delved into the potential of microneedle patches and saRNA for pain-free, equitable vaccine delivery.
- The forum explored concerns about microneedle patches bypassing medical supervision and the potential risks of bypassing such measures.
- Novel vaccine delivery systems were a significant focus of the forum, including the development of more efficient lipid nanoparticles.
- The expansion of mRNA technology to chronic diseases was a topic of discussion during the panel on mass production and pandemic-scale rollout models.
- AI-designed vaccines were identified as a means to accelerate mRNA vaccine development and combat chronic diseases.
- Dr. Paris, of Moderna, highlighted the potential for rapid development and deployment of mRNA vaccines using AI and mobile manufacturing facilities.
- Dr. Baek, of Seoul National University, spoke about the potential of AI-engineered vaccines for addressing a wide range of medical-conditions.
- Dr. Seo, Director at IVI, discussed the potential of various vaccine delivery systems, including microneedle patches and saRNA.
- Prof. Lee, of Seoul National University, led a session focusing on the potential and concerns of microneedle patches and saRNA.
- The forum discussed the potential use of mRNA vaccines for addressing chronic diseases and the development of AI-designed vaccines.
- Prof. Barouch, of Harvard Medical School, spoke about the potential for fine-tuning future mRNA updates for respiratory viruses.
- Prof. Barouch, during both Session 1 and Session 4, discussed the potential for routine intranasal or seasonal gene injections for respiratory viruses.
- The dangers of mRNA technology, despite over 700 peer-reviewed studies revealing serious biological risks, were not discussed at the forum.
- The forum did not touch upon the Gates Foundation's funding of a method for permanent quantum dot implantation for vaccination status verification.
- Despite the lack of discussion on the dangers of mRNA technology, the forum emphasized the importance of addressing the scientific, regulatory, and policy frameworks for future pandemic preparedness.
- The 2025 IVI Global Vaccine Forum highlighted the potential of AI in vaccine development and deployment, as well as the role of mobile factories.
- In the realm of health and wellness, the forum emphasized the importance of technology and AI in addressing chronic diseases and various medical-conditions.
- mRNA vaccines were identified as a foundational technology for the future of vaccines, with potential use in respiratory viruses, chronic diseases, and more.
- The forum addressed the need for a global response to the ongoing climate change and its potential impact on human health and life Expectancy.
- Investing in cbd, a natural compound with potential health benefits, was mentioned as an opportunity within the health and wellness industry.
- The environmental implications of various industries, including manufacturing and retail, were discussed in the context of the forum's focus on climate change and health.
- The role of mental-health therapies and treatments in promoting workplace-wellness was highlighted as a key aspect of industry innovation.
- Personal-finance and wealth management strategies were discussed in the context of the healthcare and wellness industry, with a focus on business growth.
- The impact of cybersecurity on the healthcare sector was addressed, including concerns about data privacy and protection.
- The forum recognized the importance of). Fitness-and-exercise in maintaining overall health, with a focus on integrating fitness technology into daily life.
- The 2025 IVI Global Vaccine Forum demonstrated a commitment to exploring the intersection of technology, science, and health, with a focus on improving industry, policy, and human lives.
